{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:33:51Z","timestamp":1789947231201,"version":"4.0.1"},"reference-count":51,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1080\/10428190500126463","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T13:34:24Z","timestamp":1126100064000},"page":"1261-1268","source":"Crossref","is-referenced-by-count":33,"title":["Importance of Plasma Matrix Metalloproteinases (MMP) and Tissue Inhibitors of Metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia"],"prefix":"10.1080","volume":"46","author":[{"given":"Jen Chin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197109000-00001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421706"},{"key":"CIT0003","first-page":"189","volume":"51","author":"Jacobson RJ","year":"1978","journal-title":"Fialkow PJ. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood"},{"key":"CIT0004","first-page":"184","volume":"80","author":"Wang JC","year":"1992","journal-title":"Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200368"},{"key":"CIT0006","first-page":"46","volume":"54","author":"Michiels JJ","year":"1999","journal-title":"Diagnosis, pathogenesis and treatment of the myelopro-liferative disorders essential hrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Neth J Med"},{"key":"CIT0007","first-page":"1046","volume":"59","author":"Castro-Malaspina H","year":"1982","journal-title":"Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood"},{"key":"CIT0008","first-page":"441","volume":"97","author":"Martyre MC","year":"1997","journal-title":"Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(97)90022-9"},{"key":"CIT0010","first-page":"9","volume":"88","author":"Martyre MC","year":"1994","journal-title":"Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol"},{"key":"CIT0011","first-page":"G245\u2013G249","volume":"279","author":"Arthur MW","year":"2000","journal-title":"Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol"},{"key":"CIT0014","first-page":"14313","volume":"270","author":"Apte SS","year":"1995","journal-title":"The gene structure of tissue inhibitor of metalloproteinase (TIMP) and its inhibitory activities define the distinct TIMP gene family. J Biol Chem"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.48.6.1014"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.31.21491"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/nrm763"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.17.1.463"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4838(99)00279-4"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1042\/bj2680267"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3293146.x"},{"key":"CIT0023","first-page":"219","volume":"76","author":"Welgus HG","year":"1985","journal-title":"Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Chin Invest"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982575"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1979.tb05843.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb07535.x"},{"key":"CIT0029","first-page":"171","volume":"99","author":"Lisse I","year":"1991","journal-title":"Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study. APMIS"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08905.x"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07465.x"},{"key":"CIT0033","first-page":"18","volume":"33","author":"Hasselbalch H","year":"1990","journal-title":"Procollagen type III amino-terminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy. Am J Hematol"},{"key":"CIT0034","first-page":"171","volume":"65","author":"Wang JC","year":"1987","journal-title":"Immunoreactive propyl hydroxylase activity in patients with primary and secondary myelofibrosis. Br J Haematol"},{"key":"CIT0035","first-page":"276","volume":"71","author":"Jensen MK","year":"2003","journal-title":"Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism. Eur J Haematol"},{"key":"CIT0036","first-page":"43","volume":"69","author":"Jensen MK","year":"2002","journal-title":"Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera. Eur J Haematol"},{"key":"CIT0037","first-page":"383","volume":"55","author":"Wang JC","year":"1980","journal-title":"Urinary hydroxyproline excretion in myelofibrosis. Blood"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03874.x"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00096.x"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290021542"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074357"},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","volume":"261","author":"Ignotz RA","year":"1986","journal-title":"J Biol Chem"},{"key":"CIT0045","first-page":"2977","volume":"7","author":"Pearson CA","year":"1988","journal-title":"Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J"},{"key":"CIT0046","first-page":"1899","volume":"6","author":"Edwards DR","year":"1987","journal-title":"Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J"},{"key":"CIT0048","first-page":"6040","volume":"154","author":"Battegay EJ","year":"1995","journal-title":"Dependence on plate-let-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol"},{"key":"CIT0049","first-page":"187","volume":"31","author":"Kallio E","year":"1999","journal-title":"Inhibition of obliterative bronchiolitis by platelet - derived growth factor receptor protein-tyrosine kinase inhibitor. Transplant Proc"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/0955-2235(89)90012-4"},{"key":"CIT0052","first-page":"80","volume":"77","author":"Martyr\u00e9 MC","year":"1991","journal-title":"Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-fl in patients with myelofi-brosis with myeloid metaplasia. Brit J Haematol"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/5.10.950"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20154"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1159\/000076545"},{"key":"CIT0060","first-page":"82","volume":"66","author":"Kurogi T","year":"1996","journal-title":"Koono M. Stimulation of gelatinase B and tissue inhibitors of metallo-proteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int J Cancer"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1913"},{"key":"CIT0064","first-page":"2022\u2014 36","volume":"96","author":"Fortunel NO","year":"2000","journal-title":"Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.07.006"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00069-3"},{"key":"CIT0068","first-page":"271b","volume":"16","author":"Hemavathy K","year":"2004","journal-title":"Analysis of transform-ing growth factor receptor type II in patients with Agnogenic Myeloid Metaplasia (AMM). Blood (Suppl)"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190500126463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T03:37:20Z","timestamp":1626493040000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190500126463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,8,3]]},"published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1080\/10428190500126463"],"URL":"https:\/\/doi.org\/10.1080\/10428190500126463","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}